Rexahn Pharma (RNN) Reports Q1 Loss of $0.02

Rexahn Pharma (NYSE: RNN) reported Q1 EPS of ($0.02), versus ($0.02) reported last year.

For earnings history and earnings-related data on Rexahn Pharma (RNN) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Benchmark Reiterates Hold Rating on Codexis, Inc. (CDXS) Amid Transition to New Products/Services
• Walmart shares fall despite earnings beat